Back to search

Article

Serum proteomic profiling reveals MTA2 and AGO2 as novel prognostic biomarkers associated with disease activity and adverse outcomes in multiple myeloma

2022-06-06

Abstract excerpt

<h4>Background: </h4> Multiple myeloma (MM) is an incurable plasma cell malignancy. Several studies have demonstrated usefulness of the proteomic approach to identify potential biomarkers in various malignancies; however, data in patients with MM are limited. Identifying novel biomarkers that can reliably indicate disease activity, progression and patient outcomes remains a major challenge. This study aimed to ide...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f932aca2-5695-50f5-9a53-7ad61e481025
DOI
10.21203/rs.3.rs-1721974/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Serum proteomic profiling reveals MTA2 and AGO2 as novel prognostic biomarkers associated with disease activity and adverse outcomes in multiple myelomaDOI 10.21203/rs.3.rs-1721974/v1
Role of Non-Coding RNAs in Diagnosis, Prediction and Prognosis of Multiple MyelomaSemantic proximity
Proteomics and functional study reveal marginal zone B and B1 cell specific protein as a candidate marker of multiple myelomaSemantic proximity
Expression Status and Prognostic Roles of m6A-related Genes in Multiple Myeloma: YTHDF2 as the independent prognostic factorSemantic proximity
Integrated Proteomic and Network Analysis Reveals Dysregulated Pathways and Candidate Proteins in Multiple Myeloma ProgressionSemantic proximity
Research Progress of Protein Arginine Methyltransferases (PRMTs) in Multiple Myeloma: From Molecular Mechanisms to Targeted TherapySemantic proximity
Revised International Staging System (R-ISS) stage-dependent analysis uncovers oncogenes and potential immunotherapeutic targets in multiple myeloma (MM)Semantic proximity
High expression of UBE2T predicts poor prognosis and survival in multiple myelomaSemantic proximity
Multiple Myeloma: Genetic and Epigenetic Biomarkers with Clinical PotentialSemantic proximity
Genome-Wide Identification of Potential Biomarkers in Multiple Myeloma Using Meta-Analysis of mRNA and miRNA Expression DataSemantic proximity
Revised International Staging System (R-ISS) stage-dependent analysis uncovers oncogenes and potential immunotherapeutic targets in multiple myelomaSemantic proximity
Identification of four potential predicting miRNA biomarkers for multiple myeloma from published datasetsSemantic proximity
The role of circulating miRNAs in multiple myelomaSemantic proximity
Select a neighboring publication to make it the new centre.